Terms: = Bone cancer AND IGL AND Treatment
5 results:
1. Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemia.
Mai H; Li Q; Wang G; Wang Y; Liu S; Tang X; Chen F; Zhou G; Liu Y; Li T; Wang L; Wang C; Wen F; Liu S
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3259-3266. PubMed ID: 35918464
[TBL] [Abstract] [Full Text] [Related]
2. Assessment of Clonotypic Rearrangements and Minimal Residual Disease in Lymphoid Malignancies.
Hussaini MO; Srivastava J; Lee LW; Nishihori T; Shah BD; Alsina M; Pinilla-Ibarz J; Shain KH
Arch Pathol Lab Med; 2022 Apr; 146(4):485-493. PubMed ID: 34343238
[TBL] [Abstract] [Full Text] [Related]
3. Staging bone marrow in diffuse large B-cell lymphoma: the role of ancillary investigations.
Talaulikar D; Dahlstrom JE
Pathology; 2009; 41(3):214-22. PubMed ID: 19291532
[TBL] [Abstract] [Full Text] [Related]
4. The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma.
Moskowitz CH; Nimer SD; Glassman JR; Portlock CS; Yahalom J; Straus DJ; O'Brien JP; Elkin N; Bertino JR; Zelenetz AD
Bone Marrow Transplant; 1999 Mar; 23(6):561-7. PubMed ID: 10217186
[TBL] [Abstract] [Full Text] [Related]
5. High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma.
Petersen FB; Appelbaum FR; Bigelow CL; Buckner CD; Clift RA; Sanders JE; Storb R; Sullivan KM; Weiden PL; Fefer A
Bone Marrow Transplant; 1989 Sep; 4(5):483-8. PubMed ID: 2676043
[TBL] [Abstract] [Full Text] [Related]
